Interleukin-1β downregulates the L-type Ca2+ channel activity by depressing the expression of channel protein in cortical neurons

Journal of Cellular Physiology

Volumn 206, Issue 3, 2006, Pages 799-806

  Zhou, Chen ^a   Tai, Chao ^a   Ye, Hai Hong ^b   Ren, Xi ^a   Chen, Jian Gou ^a   Wang, Shi Qiang ^a   Chai, Zhen ^a  

^a PEKING UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; INTERLEUKIN 1BETA; INTERLEUKIN 1;

ANIMAL CELL; ARTICLE; BRAIN CELL; CALCIUM CONDUCTANCE; CALCIUM CURRENT; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FETUS; IMMUNOBLOTTING; NERVE CELL; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; BRAIN CORTEX; CALCIUM SIGNALING; CELL CULTURE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALIA;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELLS, CULTURED; CEREBRAL CORTEX; DOWN-REGULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; IMMUNOBLOTTING; INTERLEUKIN-1; ION CHANNEL GATING; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 31944436029     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20518     Document Type: Article

References (37)

1. Cai Z, Pang Y, Lin S, Rhodes PG. 2003. Differential roles of tumor necrosis factor-α and interleukin-1β in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975:37-47.
2. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. 1999. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163:3963-3968.
3. Colecraft HM, Brody DL, Yue DT. 2000. G-protein inhibition of N- and P/Q-type calcium channels: Distinctive elementary mechanisms and their functional impact. J Neurosci 21:1137-1147.
4. v1.2 during aging. Proc Natl Acad Sci USA 100:16018-16023.
5. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ. 1999. The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87-98.
6. Diochot S, Richard S, Valmier J. 1995. Diversity of voltage-gated calcium currents in large diameter embryonic mouse sensory neurons. Neurosci 69: 627-641.
7. Eckert R, Tillotson DL. 1981. Calcium-mediated inactivation of the calcium conductance in caesium-loaded giant neurones of Aplysia caiifornica. J Physiol 314:265-280.
8. Griffin WS, Mrak RE. 2002. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 72:233-238.
9. Hell JW, Yokoyama CT, Wong ST, Warner C, Snutch TP, Catterall WA. 1993. Differential phosphorylation of two size forms of the neuronal class C L-type calcium channel α1 subunit. J Biol Chem 268:19451-19457.
10. Herx LM, Rivest S, Yong VW. 2000. Central nervous system-initiated inflammation and neurotrophism in trauma. J Immunol 165:2232-2239.
11. Jassar BS, Harris KH, Ostashewski PM, Jhamandas JH. 1999. Ionic mechanisms of action of neurotensin in acutely dissociated neurons from the diagonal band of broca of the rat. J neurophysiol 81:234-246.
12. Kavalali ET, Hwang KS, Plummer MR. 1997. cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J Neurosci 17:5334-5348.
13. Legos JJ, Whitmore RG, Erhardt JA, Parsons AA, Tuma RF, Barone FC. 2000. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci Lett 282:189-192.
14. Li Y, Liu L, Rang J, Sheng JG, Barger SW, Mark RE, Griffin WS. 2000. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 20:149-155.
15. 2+ current by interleukin-1β in cultured rat ventricular myocytes. Am J Physiol 268:C339-C349.
16. 2+ current by IL-1β in rat ventricular myocytes. Am J Physiol 276:H141-H148.
17. 2+ channel activity by β-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. J Biol Chem 275:4713-4718.
18. 2+ concentration and catecholamine release in adrenal chromaffin cells. Biochim Biophys Acta 1673:160-169.
19. Nakajima K, Nagata K, Kamanoue M, Takemoto N, Shimada A, Kohsaka S. 1993. Plasminogen-binding protein associated with the plasma membrane of cultured embryonic rat neocortical neurons. FEBS 333:223-228.
20. Nowycky MC, Fox AP, Tsien RW. 1985. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. Proc Natl Acad Sci USA 82:2178-2182.
21. Patel HC, Boutin H, Allan SM. 2003. Interleukin-1 in the brain: Mechanisms of action in acute neurodegeneration. Ann NY Acad Sci 992:39-47.
22. Pierrot N, Ghisdal P, Caumont A, Octave J. 2004. Intraneuronal amyloid-β1-42 production triggered by sustained increase of cytosolic calcium concentration-induces neuronal death. J Neurochem 88:1140-1150.
23. 2+ channel current in hippocampal neurons through protein kinase C. Eur J Pharmacol 266:1-10.
24. Porter NM, Thibault O, Thibault V, Chen K, Landfield PW. 1997. Calcium channel density and hippocampal cell death with age in long-term culture. J Neurosci 17:5629-5639.
25. Prehn JH. 1996. Marked diversity in the action of growth factors on N-methyl-D-aspartate-induced neuronal degeneration. Eur J Pharmacol 306:81-88.
26. 2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron. J Neurosci 21:3721-3728.
27. Ringheim GE, Burgher KL, Heroux JA. 1995. Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol 63:113-123.
28. Rothwell NJ. 2003. Interleukin-1 and neuronal injury: Mechanisms, modification, and therapeutic potential. Brain Behav Immun 17:152-157.
29. Rothwell NJ, Luheshi GN. 2000. Interleukin-1 in the brain: Biology, pathology, and therapeutic target. Trends Neurosci 23:618-625.
30. Spafford JD, Zamponi GW. 2003. Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery. Curr Opin Neurobiol 13:308-314.
31. Stevens TR, Kureger SR, Fitzsimonds RM, Picciotto MR. 2003. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 23:10093-10099.
32. Strijbos P, Rothwell NJ. 1995. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: Involvement of nerve growth factor. J Neurosci 15:3468-3474.
33. Stroemer RP, Rothwell NJ. 1998. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat. J Cereb Blood Flow Metab 18:833-839.
34. Thorns V, Walter GF, Licastro F. 2002. Effects of IL6 and IL-1β on aFGF expression and excitotoxicity in NT2N cells. J Neuroimmunol 127:22-29.
35. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Diluca M, Galli CL, Marinovich M. 2003. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-8700.
36. Yagami T, Ueda K, Kakaeda T, Itoh N, Sakaguchi G, Okamura N, Hori Y, Fujimoto M. 2004. Protective effect of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharma 67:1153-1165.
37. Zhao B, Schwarts JP. 1998. Involvement of cytokines in normal CNS development and neurological diseases. J Neurosci Res 52:7-16.